DDInter38 DDInter258
Aldesleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. Genetic engineering techniques were used to modify the human IL-2 gene, and the resulting expression clone encodes a modified human interleukin-2. This recombinant form differs from native interleukin-2 in the following ways: a) Aldesleukin is not glycosylated because it is derived from E. coli; b) the molecule has no N-terminal alanine; the codon for this amino acid was deleted during the genetic engineering procedure; c) the molecule has serine substituted for cysteine at amino acid position 125.
A synthetic morphinan analgesic with narcotic antagonist action. It is used in the management of severe pain.
Aldesleukin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Naltrexone
Naltrexone {u} (Compound) resembles {v} (Compound) Butorphanol
Aldesleukin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Pentazocine
Pentazocine {u} (Compound) resembles {v} (Compound) Butorphanol
Aldesleukin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Naltrexone
Naltrexone {u} may lead to a major life threatening interaction when taken with {v} Dezocine
Dezocine {u} (Compound) resembles {v} (Compound) Butorphanol
Aldesleukin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Dezocine
Dezocine {u} (Compound) resembles {v} (Compound) Levallorphan
Levallorphan {u} (Compound) resembles {v} (Compound) Butorphanol
Aldesleukin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Pentazocine
Pentazocine {u} (Compound) resembles {v} (Compound) Levallorphan
Levallorphan {u} (Compound) resembles {v} (Compound) Butorphanol
Aldesleukin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Nalbuphine
Nalbuphine {u} (Compound) resembles {v} (Compound) and {u} may lead to a major life threatening interaction when taken with {v} Naltrexone
Naltrexone {u} (Compound) resembles {v} (Compound) Butorphanol
Aldesleukin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Naltrexone
Naltrexone {u} may lead to a major life threatening interaction when taken with {v} Pentazocine
Pentazocine {u} (Compound) resembles {v} (Compound) Butorphanol
Aldesleukin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Dezocine
Dezocine {u} may lead to a major life threatening interaction when taken with {v} Naltrexone
Naltrexone {u} (Compound) resembles {v} (Compound) Butorphanol
Aldesleukin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Dezocine
Dezocine {u} (Compound) resembles {v} (Compound) Pentazocine
Pentazocine {u} (Compound) resembles {v} (Compound) Butorphanol
Aldesleukin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Chlorzoxazone
Chlorzoxazone {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Naltrexone
Naltrexone {u} (Compound) resembles {v} (Compound) Butorphanol
Aldesleukin may cause a moderate interaction that could exacerbate diseases when taken with Naltrexone and Naltrexone (Compound) resembles Butorphanol (Compound)
Aldesleukin may cause a moderate interaction that could exacerbate diseases when taken with Pentazocine and Pentazocine (Compound) resembles Butorphanol (Compound)
Aldesleukin may cause a moderate interaction that could exacerbate diseases when taken with Naltrexone and Naltrexone may lead to a major life threatening interaction when taken with Dezocine and Dezocine (Compound) resembles Butorphanol (Compound)
Aldesleukin may cause a moderate interaction that could exacerbate diseases when taken with Dezocine and Dezocine (Compound) resembles Levallorphan (Compound) and Levallorphan (Compound) resembles Butorphanol (Compound)
Aldesleukin may cause a moderate interaction that could exacerbate diseases when taken with Pentazocine and Pentazocine (Compound) resembles Levallorphan (Compound) and Levallorphan (Compound) resembles Butorphanol (Compound)
Aldesleukin may cause a moderate interaction that could exacerbate diseases when taken with Nalbuphine and Nalbuphine (Compound) resembles Naltrexone (Compound) and Nalbuphine may lead to a major life threatening interaction when taken with Naltrexone and Naltrexone (Compound) resembles Butorphanol (Compound)
Aldesleukin may cause a moderate interaction that could exacerbate diseases when taken with Naltrexone and Naltrexone may lead to a major life threatening interaction when taken with Pentazocine and Pentazocine (Compound) resembles Butorphanol (Compound)
Aldesleukin may cause a moderate interaction that could exacerbate diseases when taken with Dezocine and Dezocine may lead to a major life threatening interaction when taken with Naltrexone and Naltrexone (Compound) resembles Butorphanol (Compound)
Aldesleukin may cause a moderate interaction that could exacerbate diseases when taken with Dezocine and Dezocine (Compound) resembles Pentazocine (Compound) and Pentazocine (Compound) resembles Butorphanol (Compound)
Aldesleukin may cause a moderate interaction that could exacerbate diseases when taken with Chlorzoxazone and Chlorzoxazone may cause a moderate interaction that could exacerbate diseases when taken with Naltrexone and Naltrexone (Compound) resembles Butorphanol (Compound)